JSSH
WST icon

J. Safra Sarasin Holding’s West Pharmaceutical WST Stock Holding History

J. Safra Sarasin Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
+5,450
New +$1.67M 0.03% 269
2025
Q4 		– Sell
-3,449
Closed -$905K – 561
2025
Q3 		$905K Buy
3,449
+640
+23% +$156K 0.01% 323
2025
Q2 		$615K Sell
2,809
-134
-5% -$28.6K 0.01% 341
2025
Q1 		$659K Sell
2,943
-263
-8% -$72.5K 0.01% 387
2024
Q4 		$1.05M Sell
3,206
-7,952
-71% -$2.5M 0.02% 315
2024
Q3 		$3.35M Sell
11,158
-350
-3% -$107K 0.06% 161
2024
Q2 		$3.79M Buy
+11,508
New +$4.07M 0.07% 153

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

J. Safra Sarasin Holding's WST Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in West Pharmaceutical (WST) in Q2 2026: 5,450 shares worth $1.96M. The stake represents 0.03% of the portfolio and ranks #269 among its holdings. This is a return to the name: J. Safra Sarasin Holding previously reported a position in WST as recently as Q3 2025.

J. Safra Sarasin Holding first reported a position in WST in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.79M in Q2 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • J. Safra Sarasin Holding held 5,450 shares of West Pharmaceutical worth $1.96M as of Q2 2026.
  • West Pharmaceutical was a new J. Safra Sarasin Holding position in Q2 2026.
  • West Pharmaceutical made up 0.03% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #269 holding.
  • J. Safra Sarasin Holding first reported a position in West Pharmaceutical in Q2 2024 and has held it in 7 quarters since.
  • J. Safra Sarasin Holding's West Pharmaceutical position peaked at $3.79M in Q2 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.